[Pseudomonas Aeruginosa: Pathogenicity and Antimicrobial Resistance in Urinary Tract Infection]
Overview
Authors
Affiliations
Among the most frequent nosocomial infections associated with polyresistant bacteria and with a worse prognosis, are those produced by Pseudomonas aeruginosa. This bacterium has a high capacity to adapt to adverse conditions such as pH and osmolarity of urine. Pseudomonas aeruginosa is one of the main pathogens involved in nosocomial infections and immunosuppressed patients. This bacterium is considered an opportunistic infectious agent that has diverse mechanisms of pathogenicity, as well as resistance to antimicrobials, which contributes to the difficulty in the treatment of these infections. In the present bibliographic review, the taxonomy, pathogenicity mechanisms and resistance genes of P. aeruginosa are analyzed. Likewise, the micro-environmental factors of the urinary infection produced by this bacterium are approached, making an approach to the understanding of the pathophysiological bases of this infection.
Tovar-Carrillo K, Trujillo-Morales L, Cuevas-Gonzalez J, Rios-Arana J, Espinosa-Cristobal L, Zaragoza-Contreras E Gels. 2024; 10(9).
PMID: 39330208 PMC: 11431176. DOI: 10.3390/gels10090606.
Aroca Molina K, Gutierrez S, Benitez-Campo N, Correa A Microorganisms. 2024; 12(6).
PMID: 38930498 PMC: 11205572. DOI: 10.3390/microorganisms12061116.
A Novel Bacteriophage Infecting Multi-Drug- and Extended-Drug-Resistant Strains.
Santamaria-Corral G, Pagan I, Aguilera-Correa J, Esteban J, Garcia-Quintanilla M Antibiotics (Basel). 2024; 13(6).
PMID: 38927189 PMC: 11200629. DOI: 10.3390/antibiotics13060523.
Contreras-Martinez O, Sierra-Quiroz D, Angulo-Ortiz A Plants (Basel). 2024; 13(10).
PMID: 38794482 PMC: 11126144. DOI: 10.3390/plants13101412.
In Vitro Antimicrobial Photodynamic Therapy for () and (MRSA) Inhibition Using a Green Light Source.
Roa-Tort K, Saavedra Y, Villanueva-Martinez A, Ganem-Rondero A, Perez-Carranza L, de la Rosa-Vazquez J Pharmaceutics. 2024; 16(4).
PMID: 38675180 PMC: 11053950. DOI: 10.3390/pharmaceutics16040518.